BioTelemetry (BEAT) Tops Q1 EPS by 1c; Raises Revenue Otulook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
April 25, 2019 4:05 PM EDTAchieves Record Quarterly Revenue
Raises Full Year 2019 Guidance
MALVERN, Pa., April 25, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2019.
Quarter Highlights
Recognized record quarterly revenue of $104.0 millionReached 10.0% year-over-year revenue growthAchieved 27th consecutive quarter of year-over-year revenue growthReported GAAP net income of $11.7 millionRealized quarterly adjusted EBITDA of $28.8 million, or 27.7% of... More